Modulation of blood sugar level and lipid profiles by schiff base of (E)-3-(1H-imidazol-4-yl)-2-((2-oxoindolin-3-ylidene) amino) propanoicacid derivatives in streptozotocin-induced type II diabetic rats
Open Access
- 1 September 2021
- journal article
- research article
- Published by CMV Verlag in MEDICAL SCIENCES JOURNAL
- Vol. 31 (3) , 319-327
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- By the numbers: New estimates from the IDF Diabetes Atlas Update for 2012Diabetes Research and Clinical Practice, 2012
- Synthesis, characterization and biological activity of transition metal complexes with Schiff bases derived from 2-nitrobenzaldehyde with glycine and methionineSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2012
- Simple isatin derivatives as free radical scavengers: Synthesis, biological evaluation and structure-activity relationshipBMC Chemistry, 2011
- Synthesis of bis-Schiff bases of isatins and their antiglycation activityBioorganic & Medicinal Chemistry, 2009
- Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsBioorganic & Medicinal Chemistry, 2009
- Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic ratsPhytomedicine, 2006
- Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agentsEuropean Journal of Medicinal Chemistry, 2006
- Global and societal implications of the diabetes epidemicNature, 2001
- Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic ratsDiabetologia, 1995
- Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agentsDiabetologia, 1988